The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
ConditionUlcerative Colitis
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age7-21
SponsorChildren's Hospital Los Angeles
About this trial
Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative colitis. This is a feasibility study to determine the efficacy of butryate enemas in pediatric ulcerative colitis.
Eligibility criteria
Qualifiers
7-21 years, mild to moderate ulcerative colitis
Disqualifiers
UC therapy within 4 weeks of study medication initiation
infectious colitis, -pregnancy
Trial design
Treatments tested in this trial
- Butyrate
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov